Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcutis Biotherapeutics (ARQT) EPS (Basic): 2021-2025

Historic EPS (Basic) for Arcutis Biotherapeutics (ARQT) over the last 5 years, with Sep 2025 value amounting to $0.06.

  • Arcutis Biotherapeutics' EPS (Basic) rose 118.18% to $0.06 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.35, marking a year-over-year increase of 78.92%. This contributed to the annual value of -$1.16 for FY2024, which is 69.31% up from last year.
  • Per Arcutis Biotherapeutics' latest filing, its EPS (Basic) stood at $0.06 for Q3 2025, which was up 146.15% from -$0.13 recorded in Q2 2025.
  • Arcutis Biotherapeutics' EPS (Basic)'s 5-year high stood at $0.06 during Q3 2025, with a 5-year trough of -$1.89 in Q3 2022.
  • Its 3-year average for EPS (Basic) is -$0.47, with a median of -$0.33 in 2024.
  • Per our database at Business Quant, Arcutis Biotherapeutics' EPS (Basic) crashed by 67.11% in 2022 and then surged by 118.18% in 2025.
  • Quarterly analysis of 5 years shows Arcutis Biotherapeutics' EPS (Basic) stood at -$1.43 in 2021, then increased by 20.28% to -$1.14 in 2022, then soared by 48.25% to -$0.59 in 2023, then spiked by 86.44% to -$0.08 in 2024, then spiked by 118.18% to $0.06 in 2025.
  • Its EPS (Basic) stands at $0.06 for Q3 2025, versus -$0.13 for Q2 2025 and -$0.20 for Q1 2025.